Clinical Trial Update: First in Man Trial - BIOSOLVE-I [NA]

View source ↗

Summary

First-in-man BIOSOLVE-I trial update reporting completion of an early-stage evaluation for de novo lesions in native coronary arteries.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Biotronik AG | Conditions: de Novo Lesions in Native Coronary Arteries | NA | Status: COMPLETED